ERY-TAB Drug Patent Profile
✉ Email this page to a colleague
When do Ery-tab patents expire, and when can generic versions of Ery-tab launch?
Ery-tab is a drug marketed by Azurity and is included in one NDA.
The generic ingredient in ERY-TAB is erythromycin. There are one hundred and three drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ery-tab
A generic version of ERY-TAB was approved as erythromycin by TORRENT on July 6th, 2020.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ERY-TAB?
- What are the global sales for ERY-TAB?
- What is Average Wholesale Price for ERY-TAB?
Summary for ERY-TAB
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 103 |
| Patent Applications: | 5,376 |
| DailyMed Link: | ERY-TAB at DailyMed |
Pharmacology for ERY-TAB
| Drug Class | Macrolide Antimicrobial Macrolide |
| Physiological Effect | Decreased Sebaceous Gland Activity |
US Patents and Regulatory Information for ERY-TAB
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Azurity | ERY-TAB | erythromycin | TABLET, DELAYED RELEASE;ORAL | 062298-001 | Approved Prior to Jan 1, 1982 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Azurity | ERY-TAB | erythromycin | TABLET, DELAYED RELEASE;ORAL | 062298-003 | Mar 29, 1982 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Azurity | ERY-TAB | erythromycin | TABLET, DELAYED RELEASE;ORAL | 062298-002 | Approved Prior to Jan 1, 1982 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
